Objective 1
Characterize the effect of parity on cytokine-mediated innate immune response during the transition
period of dairy cows.
Objective 2
Evaluate the use of an immune stimulant cytokine (polyethylene glycolated form of recombinant
bovine granulocyte colony-stimulating factor; PEG rbG-CSF) under field conditions in commercial dairy
herds.
Specific objectives
a. To evaluate the effects of use PEG rbG-CSF in the udder health and other health disorders in
primiparous and multiparous Holstein dairy cows
b. To evaluate the effects of use PEG rbG-CSF on fertility in primiparous and multiparous Holstein
dairy cows.
c. To evaluate the effects of use PEG rbG-CSF on metabolic status of primiparous and multiparous
Holstein dairy cows.
d. To evaluate the effects of use PEG rbG-CSF in immune system in primiparous and multiparous
Holstein dairy cows.
e. To make an economic evaluation of the use of PEG rbG-CSF in primiparous and multiparous
Holstein dairy cows.